Prot #1241.36: A Phase III Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin for Chronic Genotype 1 Hepatitis C Infection in an Extended Population of Treatment Naïve Patients that I

Project: Research project

Project Details

StatusFinished
Effective start/end date4/15/134/15/16

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1241.36)